Acura Pharmaceuticals Company Profile (NASDAQ:ACUR)

About Acura Pharmaceuticals

Acura Pharmaceuticals logoAcura Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in the research, development and commercialization of technologies and products intended to address medication abuse and misuse. The Company has discovered and developed three platform technologies, which can be used to develop multiple products. The Company's Oxaydo Tablets (oxycodone HCl, CII), which utilizes the Aversion Technology, is an approved and immediate-release (IR) oxycodone product in the United States. The Company's Impede technology products include Nexafed and Nexafed Sinus Pressure + Pain. Its third deterrent technology is Limitx, which is designed to retard the release of active drug ingredients when too many tablets are accidently or purposefully ingested. The Company's Aversion and Limitx technologies are intended to address methods associated with opioid and its Impede technology is directed at the extraction and conversion of pseudoephedrine into methamphetamine.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Delivery
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: ACUR
  • CUSIP: 00509L70
Key Metrics:
  • Previous Close: $0.78
  • 50 Day Moving Average: $0.7362
  • 200 Day Moving Average: $1.1466
  • 52-Week Range: $0.50 - $3.52
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.70
  • P/E Growth: 0.0000
  • Market Cap: $7.83M
  • Outstanding Shares: 11,833,000
  • Beta: 2.12
Profitability:
  • Net Margins: -291.24%
  • Return on Equity: -285.16%
  • Return on Assets: -79.77%
Debt:
  • Debt-to-Equity Ratio: -7.29%
  • Current Ratio: 1.25%
  • Quick Ratio: 1.15%
Additional Links:
Companies Related to Acura Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Acura Pharmaceuticals (NASDAQ:ACUR) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $8.00 (925.64% upside)

Analysts' Ratings History for Acura Pharmaceuticals (NASDAQ:ACUR)
Show:
DateFirmActionRatingPrice TargetDetails
10/21/2016FBR & CoReiterated RatingOutperform$10.00View Rating Details
10/18/2016Roth CapitalSet Price TargetBuy$6.00View Rating Details
7/2/2015MLV & Co.Initiated CoverageBuy$2.00View Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for Acura Pharmaceuticals (NASDAQ:ACUR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/1/2017        
11/14/2016Q3($0.27)($0.19)ViewN/AView Earnings Details
5/2/2016Q116($0.26)($0.28)ViewN/AView Earnings Details
2/29/2016Q315($0.03)($0.08)$2.70 million$2.68 millionViewListenView Earnings Details
8/3/2015Q215($0.02)($0.05)$2.90 millionViewN/AView Earnings Details
5/4/2015Q115$0.07$0.03$7.60 million$5.40 millionViewN/AView Earnings Details
3/2/2015Q414($0.09)($0.06)ViewN/AView Earnings Details
11/3/2014($0.08)($0.06)ViewN/AView Earnings Details
8/6/2014($0.08)($0.07)ViewN/AView Earnings Details
5/5/2014($0.05)($0.08)ViewN/AView Earnings Details
3/3/2014Q4 13($0.06)($0.29)ViewN/AView Earnings Details
8/1/2013Q2 2013($0.07)ViewN/AView Earnings Details
3/4/2013Q4 2012($0.86)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Acura Pharmaceuticals (NASDAQ:ACUR)
Current Year EPS Consensus Estimate: $-1.02 EPS
Next Year EPS Consensus Estimate: $-0.46 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.20)($0.20)($0.20)
Q2 20162($0.28)($0.27)($0.28)
Q3 20162($0.28)($0.25)($0.27)
Q4 20162($0.28)($0.19)($0.24)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Acura Pharmaceuticals (NASDAQ:ACUR)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Acura Pharmaceuticals (NASDAQ:ACUR)
Insider Ownership Percentage: 7.40%
Institutional Ownership Percentage: 31.23%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/17/2015Claudius LlcMajor ShareholderSell104,823$1.08$113,208.84View SEC Filing  
1/12/2015Claudius LlcMajor ShareholderSell171,000$0.62$106,020.00View SEC Filing  
5/22/2014William G SkellyDirectorSell4,600$1.23$5,658.00View SEC Filing  
5/20/2014William G SkellyDirectorSell5,000$1.21$6,050.00View SEC Filing  
5/19/2014Albert W BrzeczkoVPBuy2,000$1.20$2,400.00View SEC Filing  
5/16/2014Bruce F WessonDirectorBuy80,000$1.13$90,400.00View SEC Filing  
5/16/2014James F EmighVPBuy15,000$1.21$18,150.00View SEC Filing  
5/16/2014Peter A ClemensCFOBuy3,000$1.21$3,630.00View SEC Filing  
5/14/2014William G SkellyDirectorSell2,900$1.21$3,509.00View SEC Filing  
5/12/2014William G SkellyDirectorSell5,000$1.25$6,250.00View SEC Filing  
5/8/2014William G SkellyDirectorSell2,500$1.30$3,250.00View SEC Filing  
3/3/2014Claudius LlcMajor ShareholderSell2,500$2.00$5,000.00View SEC Filing  
2/28/2014Claudius LlcMajor ShareholderSell351,260$2.02$709,545.20View SEC Filing  
2/24/2014Claudius LlcMajor ShareholderSell44,019$1.97$86,717.43View SEC Filing  
11/25/2013Albert W BrzeczkoVPBuy1,215$1.70$2,065.50View SEC Filing  
10/10/2013Claudius LlcMajor ShareholderSell4,200$2.05$8,610.00View SEC Filing  
8/27/2013William G SkellyDirectorSell2,000$1.55$3,100.00View SEC Filing  
7/15/2013Care Capital Ii LlcMajor ShareholderSell31,610$2.04$64,484.40View SEC Filing  
7/3/2013Care Capital Ii LlcMajor ShareholderSell14,200$2.00$28,400.00View SEC Filing  
7/2/2013Claudius LlcMajor ShareholderSell200,000$2.15$430,000.00View SEC Filing  
6/27/2013Care Capital Ii LlcMajor ShareholderSell76,281$2.01$153,324.81View SEC Filing  
6/24/2013Care Capital Ii LlcMajor ShareholderSell83,000$2.03$168,490.00View SEC Filing  
6/19/2013Care Capital Ii LlcMajor ShareholderSell114,000$2.12$241,680.00View SEC Filing  
6/17/2013Claudius LlcMajor ShareholderSell20,446$2.15$43,958.90View SEC Filing  
6/14/2013Care Capital Ii LlcMajor ShareholderSell90,000$2.16$194,400.00View SEC Filing  
6/11/2013Care Capital Ii LlcMajor ShareholderSell102,000$2.19$223,380.00View SEC Filing  
6/10/2013Claudius LlcMajor ShareholderSell21,496$2.20$47,291.20View SEC Filing  
6/6/2013Claudius LlcMajor ShareholderSell39,453$2.19$86,402.07View SEC Filing  
6/3/2013Care Capital Ii LlcMajor ShareholderSell148,000$2.24$331,520.00View SEC Filing  
5/31/2013Claudius LlcMajor ShareholderSell31,559$2.25$71,007.75View SEC Filing  
5/29/2013Care Capital Ii LlcMajor ShareholderSell108,701$2.33$253,273.33View SEC Filing  
5/28/2013William G SkellyDirectorSell2,000$2.40$4,800.00View SEC Filing  
5/23/2013Care Capital Ii LlcMajor ShareholderSell252,000$2.31$582,120.00View SEC Filing  
5/22/2013William G SkellyDirectorSell4,000$2.33$9,320.00View SEC Filing  
5/21/2013Claudius LlcMajor ShareholderSell47,410$2.30$109,043.00View SEC Filing  
5/20/2013Care Capital Ii LlcMajor ShareholderSell510,000$2.36$1,203,600.00View SEC Filing  
5/16/2013Care Capital Ii LlcMajor ShareholderSell662,000$2.38$1,575,560.00View SEC Filing  
5/16/2013William G SkellyDirectorSell3,000$2.25$6,750.00View SEC Filing  
5/15/2013Claudius LlcMajor ShareholderSell183,434$2.33$427,401.22View SEC Filing  
5/13/2013Care Capital Ii LlcMajor ShareholderSell259,000$2.19$567,210.00View SEC Filing  
5/9/2013William G SkellyDirectorSell3,000$2.20$6,600.00View SEC Filing  
4/11/2013Claudius LlcMajor ShareholderSell121,454$2.23$270,842.42View SEC Filing  
3/26/2013Care Capital Ii LlcMajor ShareholderSell39,554$2.17$85,832.18View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Acura Pharmaceuticals (NASDAQ:ACUR)
DateHeadline
News IconDelta Air Lines, Inc. (NYSE:DAL) Analyst Estimates And Rating (NASDAQ:ACUR)
techknowbits.com - February 22 at 11:45 AM
News IconThe Technicals For Acura Pharmaceuticals, Inc. (ACUR) Have Been Dissected (Brutally) - NY Stock News (NASDAQ:ACUR)
nystocknews.com - February 18 at 3:17 PM
News IconDigging Up the Facts on Urban Outfitters, Inc. (URBN) (NASDAQ:ACUR)
fairydetox.org - February 16 at 8:22 PM
News IconDigging Up the Facts on Urban Outfitters, Inc. (URBN) (NASDAQ:ACUR)
fairydetox.org - February 16 at 8:22 PM
News IconDigging Up the Facts on Urban Outfitters, Inc. (URBN) (NASDAQ:ACUR)
fairydetox.org - February 16 at 8:22 PM
streetinsider.com logoAcura Pharma (ACUR) to Trade on OTC Markets After Failing to Comply with Nasdaq Listing Rule (NASDAQ:ACUR)
www.streetinsider.com - February 16 at 8:22 PM
streetinsider.com logoAcura Pharma (ACUR) to Trade on OTC Markets After Failing to Comply with Nasdaq Listing Rule (NASDAQ:ACUR)
www.streetinsider.com - February 16 at 8:22 PM
streetinsider.com logoAcura Pharma (ACUR) to Trade on OTC Markets After Failing to Comply with Nasdaq Listing Rule (NASDAQ:ACUR)
www.streetinsider.com - February 16 at 8:22 PM
smarteranalyst.com logoAcura Pharmaceuticals, Inc. (ACUR) To Delist From NASDAQ; Shares Fall 23% (NASDAQ:ACUR)
www.smarteranalyst.com - February 16 at 8:22 PM
smarteranalyst.com logoAcura Pharmaceuticals, Inc. (ACUR) To Delist From NASDAQ; Shares Fall 23% (NASDAQ:ACUR)
www.smarteranalyst.com - February 16 at 8:22 PM
smarteranalyst.com logoAcura Pharmaceuticals, Inc. (ACUR) To Delist From NASDAQ; Shares Fall 23% (NASDAQ:ACUR)
www.smarteranalyst.com - February 16 at 8:22 PM
us.rd.yahoo.com logoAcura Pharmaceuticals Common Stock To Trade On The OTCQB Market (NASDAQ:ACUR)
us.rd.yahoo.com - February 16 at 8:22 PM
us.rd.yahoo.com logoAcura Pharmaceuticals Common Stock To Trade On The OTCQB Market (NASDAQ:ACUR)
us.rd.yahoo.com - February 16 at 8:22 PM
us.rd.yahoo.com logo4:18 pm Acura Pharma to be delisted from the Nasdaq; will begin to trade under the same ticker on the OTCQB on February 23 (NASDAQ:ACUR)
us.rd.yahoo.com - February 16 at 8:22 PM
benzinga.com logo22 Biggest Mid-Day Losers For Thursday - Benzinga (NASDAQ:ACUR)
www.benzinga.com - February 16 at 3:21 PM
News IconMarket Scout: Looking at the Levels for Acura Pharmaceuticals Inc. (ACUR) - Baxter Review (NASDAQ:ACUR)
baxternewsreview.com - February 16 at 3:21 PM
News IconShares Losing Ground: Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) - Aiken Advocate (NASDAQ:ACUR)
aikenadvocate.com - February 16 at 3:21 PM
finance.yahoo.com logoAcura Pharmaceuticals Common Stock To Trade On The OTCQB Market - Yahoo Finance (NASDAQ:ACUR)
finance.yahoo.com - February 16 at 6:32 AM
News IconNoticeable Stocks to Watch: Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), Urban Outfitters Inc. (NASDAQ:URBN) - The Newburgh Press (NASDAQ:ACUR)
newburghpress.com - February 13 at 3:23 PM
News IconTechnical Trading: Focus on Shares of Acura Pharmaceuticals Inc. (ACUR) - Rives Journal (NASDAQ:ACUR)
rivesjournal.com - February 13 at 3:23 PM
News IconBioverativ Inc. (NASDAQ:BIVV)- Stocks Making Notable Moves ... - Street Wise Report (press release) (blog) (NASDAQ:ACUR)
streetwisereport.com - February 12 at 8:20 PM
News IconBioverativ Inc. (NASDAQ:BIVV)- Stocks Making Notable Moves: Acura Pharmaceuticals (NASDAQ:ACUR) - Street Wise Report (press release) (blog) (NASDAQ:ACUR)
streetwisereport.com - February 12 at 3:19 PM
News IconBioverativ Inc. (NASDAQ:BIVV)- Stocks Making Notable Moves: Acura Pharmaceuticals (NASDAQ:ACUR) - Street Wise Report (press release) (blog) (NASDAQ:ACUR)
streetwisereport.com - February 12 at 3:19 PM
istreetwire.com logoStocks To Track: Allison Transmission Holdings, Inc. (ALSN), Acura Pharmaceuticals, Inc. (ACUR), WCI Communities ... - iStreetWire (NASDAQ:ACUR)
istreetwire.com - February 10 at 3:22 PM
News IconA Look Ahead For 2 Stocks: InvenSense, Inc. (INVN), Acura ... - Post Analyst (NASDAQ:ACUR)
postanalyst.com - February 10 at 3:22 PM
News IconForward Earnings Estimate of Acura Pharmaceuticals, Inc.(ACUR ... - Highland Mirror (NASDAQ:ACUR)
www.highlandmirror.com - February 10 at 3:22 PM
News IconTraders Recap – Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), Express Scripts Holding Company (NASDAQ:ESRX) - Financial Breaking News (NASDAQ:ACUR)
wsbreakingnews.com - February 9 at 3:18 PM
News IconAcura Pharmaceuticals Inc (NASDAQ:ACUR): Is An Exposure Worth The Risk? - Insider Financial (NASDAQ:ACUR)
www.insiderfinancial.com - February 9 at 3:18 PM
News IconAcura Pharmaceuticals, Inc. (ACUR): Thoughts on the Momentum ... - Post Analyst (NASDAQ:ACUR)
postanalyst.com - February 9 at 1:25 AM
News IconMoody Stock Sees Increased Volatility Levels in Session: Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) - Aiken Advocate (NASDAQ:ACUR)
aikenadvocate.com - February 8 at 3:23 PM
istreetwire.com logo3 Notable Runners: Brocade Communications Systems, Inc. (BRCD), Acura Pharmaceuticals, Inc. (ACUR), Whiting ... - iStreetWire (NASDAQ:ACUR)
istreetwire.com - February 8 at 3:23 PM
News IconLosing Traction in Session: Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) - Aiken Advocate (NASDAQ:ACUR)
aikenadvocate.com - February 8 at 3:23 PM
investing.com logoU.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.19% (NASDAQ:ACUR)
www.investing.com - February 8 at 1:31 AM
News IconTuesday's Midday Stock Update: Acura Pharmaceuticals (ACUR), Second Sight Medical Products (EYES), TCP ... - Analyst Ratings (NASDAQ:ACUR)
www.analystratings.com - February 7 at 8:25 PM
News IconInvestor Corner: Checking the Charts for Acura Pharmaceuticals Inc. (ACUR) - Rives Journal (NASDAQ:ACUR)
rivesjournal.com - February 7 at 8:25 PM
seekingalpha.com logoAcura Pharmaceuticals Seeks To Raise $5 Million In Offering - Seeking Alpha (NASDAQ:ACUR)
seekingalpha.com - February 7 at 8:25 PM
prnewswire.com logoIPOs and Transactions: Jan 30 – Feb 3 / plus whitepaper: “Improving SEC disclosure” (NASDAQ:ACUR)
irblog.prnewswire.com - February 6 at 8:22 PM
News IconStock Trickling Lower Heading Into The Open: Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) - Aiken Advocate (NASDAQ:ACUR)
aikenadvocate.com - February 6 at 3:22 PM
realistinvestor.com logoAcura Pharmaceuticals, Inc. (NASDAQ:ACUR) EPS Projection At $-0.12 - RealistInvestor.com (NASDAQ:ACUR)
www.realistinvestor.com - February 4 at 1:28 AM
reuters.com logoBRIEF-Acura Pharmaceuticals files for secondary offering of up to $5.0 mln (NASDAQ:ACUR)
www.reuters.com - February 3 at 8:26 PM
News IconTechnical Toolbox: Investor Focus on Acura Pharmaceuticals Inc. (ACUR) - Sherwood Daily (NASDAQ:ACUR)
sherwooddaily.com - February 3 at 3:25 PM
realistinvestor.com logoDeferred Tax Assets Of Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) At $0.001 Millions - RealistInvestor.com (NASDAQ:ACUR)
www.realistinvestor.com - February 2 at 3:19 PM
News IconA look at Acura Pharmaceuticals, Inc. (NASDAQ:ACUR)'s track record of earnings - Post Analyst (NASDAQ:ACUR)
postanalyst.com - February 1 at 8:25 PM
News IconStock Tracker: Trend Analysis on Acura Pharmaceuticals Inc. (ACUR) - Sherwood Daily (NASDAQ:ACUR)
sherwooddaily.com - February 1 at 3:24 PM
News IconIs the Needle Ready to Move on Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) - Prospect Journal (NASDAQ:ACUR)
prospectjournal.com - January 31 at 8:26 PM
News IconWilliams %R Check on Shares of Acura Pharmaceuticals Inc. (ACUR) - Sherwood Daily (NASDAQ:ACUR)
sherwooddaily.com - January 31 at 3:23 PM
News IconEquity Focus: Indicator Check on Shares of Acura Pharmaceuticals Inc. (ACUR) - Sherwood Daily (NASDAQ:ACUR)
sherwooddaily.com - January 31 at 1:34 AM
News IconNewsworthy Wonder Stock: Penny Stock Investors Looking at Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) - Nelson Research (NASDAQ:ACUR)
nelsonobserver.com - January 29 at 3:18 PM
4-traders.com logoACURA PHARMACEUTICALS, INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K) (NASDAQ:ACUR)
www.4-traders.com - January 28 at 8:22 PM
biz.yahoo.com logoACURA PHARMACEUTICALS, INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or (NASDAQ:ACUR)
biz.yahoo.com - January 27 at 9:48 PM

Social

What is Acura Pharmaceuticals' stock symbol?

Acura Pharmaceuticals trades on the NASDAQ under the ticker symbol "ACUR."

Where is Acura Pharmaceuticals' stock going? Where will Acura Pharmaceuticals' stock price be in 2017?

2 brokerages have issued 12-month target prices for Acura Pharmaceuticals' shares. Their forecasts range from $6.00 to $10.00. On average, they anticipate Acura Pharmaceuticals' share price to reach $8.00 in the next twelve months.

When will Acura Pharmaceuticals announce their earnings?

Acura Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Wednesday, February, 1st 2017.

Who owns Acura Pharmaceuticals stock?

Acura Pharmaceuticals' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Deerfield Management Co. (8.67%).

How do I buy Acura Pharmaceuticals stock?

Shares of Acura Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Acura Pharmaceuticals stock cost?

One share of Acura Pharmaceuticals stock can currently be purchased for approximately $0.78.

Acura Pharmaceuticals (NASDAQ:ACUR) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Acura Pharmaceuticals (NASDAQ:ACUR)

Earnings History Chart

Earnings by Quarter for Acura Pharmaceuticals (NASDAQ:ACUR)

Dividend History Chart

Dividend Payments by Quarter for Acura Pharmaceuticals (NASDAQ:ACUR)

Last Updated on 2/22/2017 by MarketBeat.com Staff